Micro needling and melasma
Melasma is a common skin pigment disorder of women between the ages of 20 and 50. Causes of melasma include sun, ultraviolet exposure, pregnancy, oral contraceptives, and certain drugs.
Clinically, melasma is characterized by irregularly shaped hyperpigmented areas of a beige or brown color. These areas usually occur on areas of the face exposed to sun, for example, the upper lip, cheeks, and forehead.
Therapy for melasma consist of topical application of hypopigmenting agents. These agents include hydroquinone, retinoic acid and azelaic acid. Laser resurfacing has been used in the past, but side effects include persistent erythema, hypo / hyper pigmentation, and hypertrophic scarring. Dermal needling (or fractional dermabrasion) when used with topical depigmenting serum has been shown to significantly improve appearance and spectroscopic indices (Fabbrocini et al., 2011).
Dermapen® Microneedling Devices are exclusively sold to Medical and Skin Care Professionals. Use the form to the right to get started finding a Certified Dermapen® practitioner in your area.
Enter your location information to find a Dermapen Skin Care Professional.
Want to become a Dermapen Practitioner?
Medical Clinics and Spas can offer their patients the worlds most advanced microneedling treatments with Dermapen
The Dermapen Microneedling Pen provides an unparalleled response through the segmented delivery of microneedles, creating micro injuries to the epidermis (outer layer of skin) and dermis (the inner layer of skin). As a result, the micro injuries encourage the body’s innate ability to repair itself.
Every Dermapen tip is outfitted with 12 needles and features our patented technologies, which include SureSpace™ and SafLok™. Accordingly, these safety enhancements can be found in every Dermapen needle tip and pen.
Furthermore, by using SureSpace™ and SafLok™ microneedling pen technologies, practitioners can deliver their patients the safest microneedling treatment possible, while getting the best microneedling results for their patients.